Skip to main content
Erschienen in: Clinical & Experimental Metastasis 3-4/2006

01.06.2006 | Original Research Paper

Expression of a metastatic phenotype in IFNs-primed/TNFα-activated B16 murine melanoma cells: role of JAK1/PKCδ signal transduction factors

verfasst von: Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri, Lido Calorini

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 3-4/2006

Einloggen, um Zugang zu erhalten

Abstract

In previous studies, we found that IFNγ and TNFα generated by activated macrophages stimulate the metastatic potential in F10-M3 cells, a clone isolated from B16-F10 murine melanoma line. In this phenomenon, TNFα promoted the expression of a metastatic phenotype in tumor cells previously primed with IFNγ. Here, we demonstrate that IFNα or IFNβ may replace IFNγ in priming tumor cells. We also noticed that an enhancement of the expression of p55TNFα receptor was associated with the preconditioning of tumor cells with IFNγ and IFNβ. By the use of an appropriate inhibitor, we observed that JAK1 signal transduction pathway was involved in the expression of a metastatic phenotype and of p55TNFα receptor shown in IFNγ- and IFNβ-primed melanoma cells stimulated with TNFα. Furthermore, the activity of the protein kinase C (PKC) was required for IFNγ-primed melanoma cells to express a metastatic phenotype after stimulation with TNFα. In conclusion, our study shows that a metastatic phenotype was expressed in B16 murine melanoma cells stimulated with TNFα regardless of whether the cells were primed with IFNγ IFNα or IFNβ. The molecular events leading to the expression of a metastatic phenotype in F10-M3 melanoma cells are represented by: (a) an enhanced expression of p55TNFα receptor in IFNs-primed tumor cells dependent on JAK1 signal transduction pathway; and (b) an intact PKC activity during TNFα stimulation.
Literatur
1.
Zurück zum Zitat Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379PubMedCrossRef Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379PubMedCrossRef
2.
Zurück zum Zitat Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498–505PubMedCrossRef Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498–505PubMedCrossRef
3.
Zurück zum Zitat van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM (2003) The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 82:539–548PubMedCrossRef van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM (2003) The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 82:539–548PubMedCrossRef
4.
Zurück zum Zitat Hsu MY, Meier F, Herlyn M (2002) Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70:522–536PubMedCrossRef Hsu MY, Meier F, Herlyn M (2002) Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70:522–536PubMedCrossRef
5.
Zurück zum Zitat Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1–22 Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1–22
6.
Zurück zum Zitat Lync CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70:561–573CrossRef Lync CC, Matrisian LM (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70:561–573CrossRef
7.
Zurück zum Zitat Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev 4:11–22CrossRef Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev 4:11–22CrossRef
8.
Zurück zum Zitat Robinson CR, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159–187PubMedCrossRef Robinson CR, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159–187PubMedCrossRef
9.
Zurück zum Zitat Lazar-Molnar E, Hegyesi H, Toth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547–554PubMedCrossRef Lazar-Molnar E, Hegyesi H, Toth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547–554PubMedCrossRef
10.
Zurück zum Zitat Bogenrieder T, Herlyn M (2002) Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit Rev Oncol Hematol 44:1–15PubMed Bogenrieder T, Herlyn M (2002) Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit Rev Oncol Hematol 44:1–15PubMed
11.
Zurück zum Zitat Cecconi O, Calorini L, Mannini A et al (1997) Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages Clin Exp Metastas 15:94–101CrossRef Cecconi O, Calorini L, Mannini A et al (1997) Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages Clin Exp Metastas 15:94–101CrossRef
12.
Zurück zum Zitat Calorini L, Mannini A, Bianchini F et al (1999) Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin Exp Metastas 17:889–895CrossRef Calorini L, Mannini A, Bianchini F et al (1999) Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin Exp Metastas 17:889–895CrossRef
13.
Zurück zum Zitat Calorini L, Bianchini F, Mannini A et al (2002) IFN gamma and TNF alpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. Clin Exp Metastas 19:259–264CrossRef Calorini L, Bianchini F, Mannini A et al (2002) IFN gamma and TNF alpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. Clin Exp Metastas 19:259–264CrossRef
14.
Zurück zum Zitat Gattoni-Celli S, Calorini L, Simile M.M, Ferrone S (1993) Modulation by MHC Class I antigens of the biology of melanoma cells. Non-immunological mechanisms. Melanoma Res 3:285–289PubMed Gattoni-Celli S, Calorini L, Simile M.M, Ferrone S (1993) Modulation by MHC Class I antigens of the biology of melanoma cells. Non-immunological mechanisms. Melanoma Res 3:285–289PubMed
15.
Zurück zum Zitat Chen TR (1977) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain, Exp Cell Res 104:255–262PubMedCrossRef Chen TR (1977) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain, Exp Cell Res 104:255–262PubMedCrossRef
16.
Zurück zum Zitat Thompson JE, Cubbon RM, Cummings RT et al (2002) Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 12:1219–1223PubMedCrossRef Thompson JE, Cubbon RM, Cummings RT et al (2002) Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 12:1219–1223PubMedCrossRef
17.
Zurück zum Zitat Way KJ, Chou E, King GL (2000) Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21:181–187PubMedCrossRef Way KJ, Chou E, King GL (2000) Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21:181–187PubMedCrossRef
18.
Zurück zum Zitat Cox AD, Garcia AM, Westwick JK, Kowalczyk JJ, Lewis MD, Brenner DA, Der CJ (1994) The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation. J Biol Chem 269 (30):19203–19206 Cox AD, Garcia AM, Westwick JK, Kowalczyk JJ, Lewis MD, Brenner DA, Der CJ (1994) The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation. J Biol Chem 269 (30):19203–19206
19.
Zurück zum Zitat Zhuang L, Wang B, Shinder GA et al (1999) TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 162:1440–1447PubMed Zhuang L, Wang B, Shinder GA et al (1999) TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 162:1440–1447PubMed
20.
Zurück zum Zitat Haliska FG, Tsao H, Wu H, Haluska FS et al (2006) Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12:2301s–2307sCrossRef Haliska FG, Tsao H, Wu H, Haluska FS et al (2006) Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12:2301s–2307sCrossRef
21.
22.
Zurück zum Zitat Johnson DR, Pober JS (1990) Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci USA 87:5183–5187PubMedCrossRef Johnson DR, Pober JS (1990) Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci USA 87:5183–5187PubMedCrossRef
23.
Zurück zum Zitat Tsujimoto M, Vilcek J (1986) Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma. J Biol Chem 261:5384–5388PubMed Tsujimoto M, Vilcek J (1986) Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma. J Biol Chem 261:5384–5388PubMed
24.
Zurück zum Zitat Carrel S, Hartmann F, Salvi S et al (1995) Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma. Int J Cancer 62:76–83PubMed Carrel S, Hartmann F, Salvi S et al (1995) Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma. Int J Cancer 62:76–83PubMed
25.
Zurück zum Zitat Mattei S, Colombo MP, Melani C et al (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853–857PubMed Mattei S, Colombo MP, Melani C et al (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853–857PubMed
26.
Zurück zum Zitat Ciotti P, Rainero ML, Nicolo G et al (1995) Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 5:41–47PubMedCrossRef Ciotti P, Rainero ML, Nicolo G et al (1995) Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 5:41–47PubMedCrossRef
27.
Zurück zum Zitat Moretti S, Pinzi C, Spallanzani A et al (1999) Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 84:160–168PubMedCrossRef Moretti S, Pinzi C, Spallanzani A et al (1999) Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 84:160–168PubMedCrossRef
28.
Zurück zum Zitat Dennis JU, Dean NM, Bennett CF et al (1998) Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett 128:65–70PubMedCrossRef Dennis JU, Dean NM, Bennett CF et al (1998) Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett 128:65–70PubMedCrossRef
29.
Zurück zum Zitat La Porta CA, Di Dio A, Porro D Comolli R (2000) Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo. Melanoma Res 10:93–102PubMedCrossRef La Porta CA, Di Dio A, Porro D Comolli R (2000) Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo. Melanoma Res 10:93–102PubMedCrossRef
30.
Zurück zum Zitat Gschwendt M, Muller HJ, Kielbassa K et al (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93–98PubMedCrossRef Gschwendt M, Muller HJ, Kielbassa K et al (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93–98PubMedCrossRef
31.
Zurück zum Zitat Kilpatrick LE, Song YH, Rossi MW, Korchak HM (2000) Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils. Am J Physiol Cell Physiol 279:C2011–C2018PubMed Kilpatrick LE, Song YH, Rossi MW, Korchak HM (2000) Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils. Am J Physiol Cell Physiol 279:C2011–C2018PubMed
Metadaten
Titel
Expression of a metastatic phenotype in IFNs-primed/TNFα-activated B16 murine melanoma cells: role of JAK1/PKCδ signal transduction factors
verfasst von
Francesca Bianchini
Antonella Mannini
Gabriele Mugnai
Salvatore Ruggieri
Lido Calorini
Publikationsdatum
01.06.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 3-4/2006
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-006-9030-1

Weitere Artikel der Ausgabe 3-4/2006

Clinical & Experimental Metastasis 3-4/2006 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.